How I use fibrinogen replacement therapy in acquired bleeding.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Blood

• Publication date

  2015-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2014-08-552000PMID 25519751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrinogen recovery and changes in fibrin‐based clot firmness after cryoprecipitate administration in patients undergoing aortic surgery involving deep hypothermic circulatory arrest

  2014cited by this paper
• Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy

  2014influential reference
• Cryoprecipitate therapy

  2014cited by this paper
• Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study.

  2014cited by this paper
• Coagulation management with factor concentrates in liver transplantation: a single‐center experience

  2014cited by this paper
• Hemotherapy algorithms for coagulopathic cardiac surgery patients.

  2014cited by this paper
• Fibrinogen concentrate in dilutional coagulopathy: a dose study in pigs

  2014cited by this paper
• Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate

  2014cited by this paper
• Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

  2014cited by this paper
• Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories

  2014cited by this paper
• Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM®-assisted strategy – feasibility and costs

  2014cited by this paper
• Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass.

  2014cited by this paper
• Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial

  2013influential reference
• Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results–guided transfusion in patients with severe trauma: a randomized feasibility trial

  2013cited by this paper
• Patient Blood Management

  2013cited by this paper
• Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study.

  2013cited by this paper
• The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.

  2013cited by this paper
• Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery

  2013cited by this paper
• The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery: An Observational Study

  2013cited by this paper
• Concepts of blood transfusion in adults.

  2013cited by this paper
• Management of bleeding and coagulopathy following major trauma: an updated European guideline

  2013influential reference
• Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.

  2013influential reference
• Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge

  2013cited by this paper
• Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission

  2013cited by this paper
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

  2013cited by this paper
• Early and individualized goal-directed therapy for trauma-induced coagulopathy

  2012cited by this paper
• Fibrinogen replacement therapy: a critical review of the literature.

  2012cited by this paper
• Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: Comparison of fibrinogen concentrate with allogeneic blood products

  2012cited by this paper
• Patient Blood Management

  2012cited by this paper
• Judith Graham Pool and the discovery of cryoprecipitate

  2012cited by this paper
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial

  2012cited by this paper
• Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients

  2012cited by this paper
• Is fresh‐frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME)

  2012cited by this paper
• Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial.

  2012cited by this paper
• The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial

  2012influential reference
• A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients

  2011cited by this paper
• FIBTEM provides early prediction of massive transfusion in trauma

  2011cited by this paper
• Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review

  2011cited by this paper
• The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.

  2011cited by this paper
• Frequency and characteristics of coagulopathy in trauma patients treated with a low- or high-plasma-content massive transfusion protocol.

  2011cited by this paper
• Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy

  2011influential reference
• Fibrinogen concentrate for management of bleeding

  2011cited by this paper
• High-dose tranexamic acid reduces blood loss in postpartum haemorrhage

  2011cited by this paper
• Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study

  2011cited by this paper
• Bleeding and management of coagulopathy.

  2011cited by this paper
• Safety of Tranexamic Acid in Women with Heavy Menstrual Bleeding: An Open-Label Extension Study

  2011cited by this paper
• Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy

  2011cited by this paper
• Standard haemostatic tests following major obstetric haemorrhage.

  2011cited by this paper
• Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma.

  2011cited by this paper
• Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.

  2011cited by this paper
• Fibrinogen concentrate use during major obstetric haemorrhage

  2010cited by this paper
• Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.

  2010cited by this paper
• The Risk-Benefit Profile of Aprotinin Versus Tranexamic Acid in Cardiac Surgery

  2010cited by this paper
• Impact of plasma transfusion in trauma patients who do not require massive transfusion.

  2010cited by this paper
• Successful rotational thromboelastometry‐guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy

  2010cited by this paper
• Gerinnungsmanagement bei traumatisch bedingter Massivblutung – Empfehlungen der Arbeitsgruppe für perioperative Gerinnung der ÖGARI

  2010cited by this paper
• Antifibrinolytic therapy: new data and new concepts.

  2010cited by this paper
• Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate

  2010cited by this paper
• The effect of plasma transfusion on morbidity and mortality: a systematic review and meta‐analysis

  2010cited by this paper
• Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders

  2010cited by this paper
• Multidisciplinary Approach to the Challenge of Hemostasis

  2010cited by this paper
• The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.

  2010cited by this paper
• Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery

  2010cited by this paper
• Use of rotation thromboelastometry (ROTEM®) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate

  2010cited by this paper
• Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.

  2009cited by this paper
• Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study

  2009influential reference
• Cryoprecipitate: the current state of knowledge.

  2009cited by this paper
• Time for changing coagulation management in trauma-related massive bleeding

  2009cited by this paper
• The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia

  2009cited by this paper
• Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.

  2009cited by this paper
• Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?

  2009cited by this paper
• Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo‐controlled clinical trial

  2009cited by this paper
• Fibrinogen concentrate – a potential universal hemostatic agent

  2009cited by this paper
• Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery

  2009cited by this paper
• The Risks of Aprotinin and Tranexamic Acid in Cardiac Surgery: A One-Year Follow-Up of 1188 Consecutive Patients

  2008cited by this paper
• Fibrinogen in Craniosynostosis Surgery

  2008cited by this paper
• Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P)

  2008cited by this paper
• Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.

  2008cited by this paper
• Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages

  2008influential reference
• The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.

  2008cited by this paper
• Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots

  2008cited by this paper
• Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.

  2008cited by this paper
• Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational study

  2008cited by this paper
• Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration

  2007cited by this paper
• The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.

  2007cited by this paper
• Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection.

  2007cited by this paper
• Management of bleeding following major trauma: a European guideline

  2007cited by this paper
• The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage

  2007influential reference
• The effect of fibrinogen concentrate on thrombocytopenia

  2007cited by this paper
• Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery.

  2007cited by this paper
• [Coagulation management during liver transplantation].

  2006cited by this paper
• Fibrinogen Concentrate Reverses Dilutional Coagulopathy Induced In Vitro by Saline but Not by Hydroxyethyl Starch 6%

  2006cited by this paper
• Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies

  2006cited by this paper
• Guidelines on the management of massive blood loss

  2006cited by this paper
• Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation.

  2006cited by this paper
• Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies

  2006cited by this paper
• Pharmacokinetic properties of a pasteurised fibrinogen concentrate.

  2005cited by this paper
• Multi-centre investigation on reference ranges for ROTEM thromboelastometry

  2005cited by this paper
• Molecular mechanisms of fibrinolysis

  2005cited by this paper
• Incidence of severe pre‐eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population‐based study: the MOMS‐B survey

  2005cited by this paper

• Harnessing nanotechnology for safer natural antithrombotics: Thyme essential oil-zein /sodium caseinate nanoparticles for managing obesity-associated thrombosis and dyslipidemia

  2026cites this paper
• Fibrinogen supplementation enhances antivenom efficacy in treating coagulopathy due to hemotoxic snakebite envenoming by Trimeresurus and Agkistrodon species in Yunnan, China

  2025cites this paper
• Advancements in Fibrinogen Replacement for Major Bleeding: Insights From Case Series

  2025influential citation
• Point-of-care visco-elastic testing for postpartum haemorrhage: A narrative review.

  2025cites this paper
• Preclinical safety and bleeding evaluation in swine for an siRNA-lipid nanoparticle that prevents excess fibrinogen synthesis.

  2025cites this paper
• Impact of fibrinogen-to-erythrocyte suspension ratio on mortality and functional outcomes in major perioperative bleeding (Approximate Dose-Equivalent of Fibrinogen-to-Erythrocyte Suspension (ADEFES) study): protocol for a prospective observational study

  2025cites this paper
• Storage of thawed cryoprecipitate for 5 days at refrigerated temperatures: A systematic review and meta‐analysis

  2025cites this paper
• Protein Displacement Dynamics on Chromium Oxide Nanoparticles: Investigating the Vroman Effect in a Binary Protein System

  2025cites this paper
• Viscoelastic Testing for Perioperative Bleeding Management

  2025cites this paper
• Exploiting the Molecular Properties of Fibrinogen to Control Bleeding Following Vascular Injury

  2025cites this paper
• Characteristics, risk factors and a risk prediction model of tocilizumab-induced hypofibrinogenemia: a retrospective real-world study of inpatients

  2025cites this paper
• KHẢO SÁT MỐI LIÊN QUAN GIỮA NỒNG ĐỘ FIBRINOGEN VÀ CÁC THÔNG SỐ PHÂN TÍCH DẠNG SÓNG ĐÔNG MÁU CWA

  2025cites this paper
• High risk and low incidence diseases: Massive hemoptysis.

  2024cites this paper
• Perioperative considerations in the paediatric patient with congenital and acquired coagulopathy

  2024cites this paper
• A British Society for Haematology guideline on the assessment and management of bleeding risk prior to invasive procedures

  2024cites this paper
• Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation

  2024cites this paper
• Recent Advances in Topical Hemostatic Materials.

  2024cites this paper
• Etiology and management of hypofibrinogenemia in trauma

  2023cites this paper
• Association between fibrinogen‐to‐albumin ratio and functional prognosis of 3 months in patients with acute ischemic stroke after intravenous thrombolysis

  2023cites this paper
• Early Goal-Directed Hemostatic Therapy for Severe Acute Bleeding Management in the Intensive Care Unit: A Narrative Review

  2023cites this paper
• Magic in a bottle? A Focused review of factor concentrates for the intraoperative treatment of acquired coagulopathy - Fibrinogen concentrate, prothrombin complex concentrate, and recombinant activated factor VII.

  2023cites this paper
• Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients.

  2023cites this paper
• Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate

  2023cites this paper
• The potential impact of coagulation factor XIII in trauma-induced coagulopathy – a retrospective case series analysis

  2023cites this paper
• Design and Development of a Clot Burst Pressure Device to Investigate Resuscitation Strategies.

  2023cites this paper
• Heparin-Immobilized Polyethersulfone for Hemocompatibility Enhancement of Dialysis Membrane: In Situ Synchrotron Imaging, Experimental, and Ex Vivo Studies

  2023cites this paper
• Advances in the development and optimization strategies of the hemostatic biomaterials

  2023cites this paper
• Anesthesia Considerations for Placenta Accreta Spectrum

  2023cites this paper
• Assessment of fibrinogen albumin ratio in patients with pregnancy-related cerebral venous thrombosis

  2023cites this paper
• Major haemorrhage: past, present and future

  2022cites this paper
• Weight-adjusted dosing of fibrinogen concentrate and cryoprecipitate in the treatment of hypofibrinogenaemic bleeding adult cardiac surgical patients: a post hoc analysis of the Fibrinogen Replenishment in cardiac surgery randomised controlled trial

  2022cites this paper
• The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation

  2022cites this paper
• Blood Product Replacement for Postpartum Hemorrhage

  2022cites this paper
• Does Intraoperative Fibrinogen Affect Blood Loss or Transfusion Practice After Aortic Arch Surgery: A Prematurely Ended Randomized Trial

  2022cites this paper
• Intravenous Hemostats: Foundation, Targeting, and Controlled-Release.

  2022cites this paper
• Gastrointestinal bleeding after endoscopic mucosal resection in a case of Peutz–Jeghers syndrome with hypofibrinogenemia: A case report

  2022cites this paper
• Preoperative Fibrinogen Level and Bleeding in Liver Transplantation for End-stage Liver Disease: A Cohort Study

  2022cites this paper
• Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia

  2022cites this paper
• Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial.

  2022cites this paper
• Real-life experiences with goal-directed prohemostatic therapy with fibrinogen concentrate, prothrombin complex concentrate, and recombinant factor VIIa: a retrospective study of 287 consecutive patients

  2022cites this paper
• Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis

  2021cites this paper
• Suppression of fibrin(ogen)-driven pathologies through controlled knockdown by lipid nanoparticle delivery of siRNA.

  2021cites this paper
• Quality Attributes of Plasma Derived Human Fibrinogen (Fibrogen-I®)

  2021cites this paper
• Polymeric Materials for Hemostatic Wound Healing

  2021cites this paper
• Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management

  2021cites this paper
• Commentary: Patient blood management in the era of coronavirus disease 2019—is anything really different?

  2021cites this paper
• Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding

  2021cites this paper
• Peri‐operative management of multiple tooth extractions in a patient with congenital hypofibrinogenemia receiving anticoagulant therapy

  2021cites this paper
• Transfusion of blood products during extracorporeal membrane oxygenation: a narrative review of rationale, indications, impact on immune function and outcome

  2021cites this paper
• Parâmetros preditores de mau prognóstico em pacientes com perda auditiva neurossensorial súbita: relação fibrinogênio/albumina vs. relação proteina C‐reativa/albumina

  2021cites this paper
• The emergency department evaluation and management of massive hemoptysis.

  2021cites this paper
• Preparation, Storage, and Characteristics of Whole Blood, Blood Components, and Plasma Derivatives

  2021cites this paper
• Clinical Uses of Blood Components

  2021cites this paper
• Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time

  2021cites this paper
• Prime Risk Factors to Act as Biomarkers for the Diagnosis of Myocardial Infarction

  2021cites this paper
• Hemostatic Agents and Blood Components Used to Stop Bleeding

  2021cites this paper
• Fibrinogen reconstitution after therapeutic apheresis: Comparison of double‐filtration plasmapheresis, plasma exchange, and immunoadsorption

  2021cites this paper
• The role of cryoprecipitate in human and canine transfusion medicine.

  2021cites this paper
• Transfusion in Pediatric Patients: Review of Evidence-Based Guidelines.

  2021cites this paper
• Highly efficient artificial blood coagulation shortcut confined on Ca-zeolite surface

  2021cites this paper
• The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency

  2021cites this paper
• Trauma of major surgery: A global problem that is not going away

  2020cites this paper
• Fibrinogen Albumin Ratio and Ischemic Stroke During Venoarterial Extracorporeal Membrane Oxygenation

  2020cites this paper
• Plasma scaffolds for islet transplantation

  2020cites this paper
• Fibrin(ogen) in human disease: both friend and foe

  2020cites this paper
• How do I manage severe postpartum hemorrhage?

  2020cites this paper
• Клиническое использование криопреципитата

  2020cites this paper
• COVID-19 and its implications for thrombosis and anticoagulation

  2020cites this paper
• Fibrinogen/Albumin ratio: A more powerful prognostic index for patients with end‐stage renal disease

  2020cites this paper
• The effect of hematocrit, fibrinogen concentration and temperature on the kinetics of clot formation of whole blood

  2020cites this paper
• Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity

  2020cites this paper
• Current perspective on fibrinogen concentrate in critical bleeding

  2020influential citation
• Research status and development potential of composite hemostatic materials.

  2020cites this paper
• Neurological involvement of coronavirus disease 2019: a systematic review

  2020cites this paper
• Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review

  2020cites this paper
• Predictor parameters for poor prognosis in patients with sudden sensorineural hearing loss: fibrinogen to albumin ratio vs C-reactive protein to albumin ratio

  2020cites this paper
• Severity-stratified and longitudinal analysis of VWF/ADAMTS13 imbalance, altered fibrin crosslinking and inhibition of fibrinolysis as contributors to COVID-19 coagulopathy

  2020cites this paper
• COVID-19 Associated Coagulopathy and Implications for its Treatment

  2020cites this paper
• Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature

  2020cites this paper
• Managing the coagulopathy associated with cardiopulmonary bypass

  2020cites this paper
• Perioperative Antifibrinolytics and Coagulation Management

  2020cites this paper
• Assessment of the effect of exogenous fibrin monomer on post-traumatic bleeding in hypofibrinogenemia caused by administration of snake venom Agkistrodon rhodostoma

  2020cites this paper
• Cryoprecipitate/Fibrinogen Concentrate Transfusions

  2020cites this paper
• Clinical guidelines for cryoprecipitate transfusions

  2020cites this paper
• Indications for Transfusion and Dosing of Blood Components

  2019cites this paper
• A Novel Frameshift Mutation in the FGA Gene (c.196 delT) Leading to Congenital Afibrinogenemia

  2019cites this paper
• Investigating the Effect of Fibrinogen Injection on Bleeding in Coronary Artery Bypass Surgery: A Clinical Trial

  2019cites this paper
• Using Plasma and Prothrombin Complex Concentrates

  2019cites this paper
• Latest insights on ABO‐incompatible living‐donor renal transplantation

  2019cites this paper
• Review of current transfusion therapy and blood banking practices.

  2019cites this paper
• Coagulation disturbances during major perioperative or traumatic bleeding

  2019cites this paper
• Coagulopathy in Cirrhotic Patients: Evaluation and Management

  2019cites this paper
• The Effect of Fibrinogen on Blood Loss After Lumbar Surgery: A Double-Blind Randomized Clinical Trial

  2019cites this paper
• Utility of fibrinogen in the coagulation screen

  2019cites this paper
• Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures

  2019cites this paper
• Managing obstetric haemorrhage: is it time for a more personalised approach?

  2019cites this paper
• The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition

  2019influential citation
• Bleeding and the Management of Hemorrhagic Disorders in Pregnancy

  2019cites this paper
• Effects of in-house cryoprecipitate on transfusion usage and mortality in patients with multiple trauma with severe traumatic brain injury: a retrospective cohort study.

  2019cites this paper
• Key decisions in a goal-directed coagulation management approach An individualised goal-directed approach to managing coagulopathy is recommended to treat bleeding trauma patients

  2018cites this paper